Argus Upgrades Abbvie (ABBV) to Buy
Get Alerts ABBV Hot Sheet
Price: $249.46 --0%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 18
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 18
Join SI Premium – FREE
Argus analyst David Toung upgraded Abbvie (NYSE: ABBV) from Hold to Buy.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $203.55 yesterday.
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy
- Citi Upgrades Zhejiang Dahua Technology (002236:CH) to Neutral
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share